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Abstract 
     
Filariasis is a disease caused by filarial worms which are transmitted by mosquito vectors. 
Filariasis may cause thickening of blood vessels and swollen lymph nodes. Almost all cases of 
filariasis are not detected until complications occur. Early detection can be done through the 
examination of peripheral blood regularly. The most commonly found Filariasis cases in 
Indonesia are caused by a Brugia malayi . Based on the report of 2009, the highest number of 
filariasis cases were in the provinces of Aceh, East Nusa Tenggara, and Papua, and the lowest 
were found in the provinces of Bali, Maluku and North Sulawesi. Microfilariae rate indicates the 
prevalence of filariasis in that area. The highest numbers of microfilariae in Indonesia were found 
in West Papua, Gorontalo and Papua provinces. Filariasis is a major disadvantage  in terms of 
economic, labor productivity  and it can cause lifelong disability. One of the efforts made in the 
global filariasis elimination program is the mass administration of  prevention drug  in which the 
WHO set a minimum target of 85%.  In Indonesia, for the year 2005 - 2009 is still at the level of 
28 to 59.48 % . The Ministry of Health has planned a program to eliminate filariasis starting in 
2014 and continue to have the acceleration program filariasis elimination untill 2020.   
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Background 
 
ilariasis (elephantiasis disease) is 
caused by filarial worms, which are 
transmitted by a mosquito vector. Some 
species of filarial worms that can be found in 
Indonesia, among others: Wuchereria 
bancrofti, Brugia malayi, and Brugia timori. 
Of the three species, the species of Brugia 
malayi filariasis cases are most commonly 
found in Indonesia.  
Microfilariae infect lymphoid tissue (lymph 
nodes). Microfilariae in the human body will 
grow into adult worms and settled in the lymph 
tissue that causes swelling of the legs and 
genital organs (Profil Kesehatan Indonesia, 
2010: 53; Pusat Data & Surveilans  
Epidemiologi, 2010; Nurjana, 2009:33).  
 According to WHO, there are about 1.3 
billion people in the world, covering more than 
83 countries, who at risk of contracting 
filariasis, and more than 60% are in Southeast 
Asia, and it is estimated that more than 120 
million people are infected, and 43 million 
people already showing clinical symptoms of 
swelling of the leg or arm (lymphoedema) or 
other body part. Filariasis is widespread, 
especially in rural areas and can infect all age 
groups from children to adults, both men and 
women (Direktorat P2B2 Ditjen PP & PL 
Kemenkes, 2010:1).  
 In Indonesia, filariasis disease remains a 
serious health problem. It is estimated that by 
2009 there were more than 125 million people 
at risk of contracting filariasis, spread over 401 
districts / cities with a number of chronic cases 
reach 11.914 cases in which microfilaria 
prevalence of about 19% or the equivalent of 
40 million inhabitants. This is the cumulative 
number of patients with newly discovered old 
and new patients (Profil Kesehatan Indonesia, 
2010:53; Direktorat P2B2 Ditjen PP & PL 
Kemenkes, 2010:1).  
 
Microfilariae and Vector  
    
 In 1889, Haga and Van Eecke first report on 
the presence of filariasis in Indonesia.  
There are 3 types of species of filarial worms 
that cause filariasis disease found in Indonesia, 
F 
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and the most widely spread is Brugia malayi. 
While Brugia timori only found in eastern 
Indonesia, including the islands of Timor, 
Flores, Rote, Alor and several small islands in 
East Nusa Tenggara, and Wuchereria 
brancrofti found in Java, Bali, West Nusa 
Tenggara and Papua (Direktorat P2B2 Ditjen 
PP & PL Kemenkes, 2010:3).  
 Humans can be infected with microfilariae by 
mosquito bites. Currently in Indonesia has 
identified as many as 23 species of mosquitoes 
belonging to the genus 5 which can act as 
vectors of filariasis, among others: Mansonia, 
Anopheles, Culex, Aedes and Armigeres. The 
main vectors for W. bancrofti type commonly 
found in rural areas of Papua, namely An. 
farauti and An. punctulatus. While W. 
bancrofti urban type found in large cities is Cx. 
quinquefasciatus. B. malayi Mansonia vectors 
are found in coastal and lowland areas (Depkes 
RI, 1999). Only species of filarial worms B. 
malayi and non-periodic subperiodik that have 
host reservoir, such as monkeys, apes, cats, 
etc. (Nurjana, 2009:35-36).    
Female filarial worms will produce 
larvae called microfilaria, which will migrate 
into the circulatory system. Elephantiasis or 
better known as elephantiasis disease is mainly 
caused by the adult worms live in the lymph 
channels, and can damage and clog the lymph 
fluid, causing swelling in the legs and arms. 
Adult worms in the lymph nodes may survive 
for 5-7 years (Direktorat P2B2 Ditjen PP & PL 
Kemenkes, 2010:1).  
 
Filariasis Infection  
    
Humans are infected through mosquito bites 
containing larval microfilariae. The larvae 
develop in the body and become infective 
mosquitoes for 1-2 weeks. The development 
of the filarial worm larvae begin entry of 
microfilariae from the mosquito to the human 
body to become adult worms takes 3 to 36 
months (Riyanto, 2010:1).  
 A healthy person can be infected with 
microfilaria worms after mosquito bites  
hundreds to thousands of times. In addition, 
there is also the influence of other factors 
such as the presence of other diseases, fatigue 
or malnutrition. Although the person has a 
strong body condition,  repeated bites of 
microfilariae infected mosquito may cause 
immunity.  
Similarly, the people who live in endemic 
areas will be more resistant than those who 
happened to be traveling to endemic areas of 
filariasis.  
 According to Riyanto (2010:1), filariasis 
disease may be initiated by the onset of 
inflammation of the lymph nodes due to 
channel through which the adult filarial 
worms, causing dilation and damage to the 
gland. Dilation of lymph nodes causing many 
plasma fluid out of blood vessels into tissues  
and skin, as well as damage it and cause 
thickening of the blood vessels, and lymph 
nodes become winding and swollen.  
  Typically, early filariasis infection 
difficult to detect until complications occur in 
the legs and genitals. To overcome this, 
peripheral blood examination needs to be done 
periodically. Blood can be taken from the 
index finger, and have it examined.  
 Early symptoms may include high fever, 
chills, muscle aches, and headache. Signs of 
the disease vary widely, can be bloody urine 
and the presence of protein in the urine or 
urinating pus in the morning. In addition, 
other symptoms may include high fever, 
inflammation of the lymph glands, as well as 
localized swelling, and inflammation of the 
veins. When infected with W. Bancrofti, the 
inflammation can occur in the testicles in 
men (Riyanto, 2010:1).  
 
Filariasis Cases in Indonesia  
    
In Indonesia, cases of filariasis is still quite 
high and showed an increase from year to 
year. This is indicated by the discovery of a 
number of cases in the last 5 years. Based on 
the data obtained from Pusat Data & 
Surveilans Epidemiologi Kementerian 
Kesehatan RI (2010), clinical cases from 
2005 to 2009 respectively were 8.243 cases, 
10.427 cases, 11.473 cases, 11.699 cases and 
11.914 cases. Filariasis cases were found in 
33 provinces in Indonesia.  
 If the number of patients to be reviewed by the 
province for the year 2009, the highest number 
of filariasis cases found in the Province of 
Nanggroe Aceh Darussalam (2.359 people), 
followed by East Nusa Tenggara (1.730 
people) and Papua (1.158 people). While the 
lowest case can be found in Bali (18 people), 
North Maluku (27 people), and North 
Sulawesi (30 people). Furthermore, if 
observed by the District, the district with the 
highest number of cases is North Aceh (1.353 
cases), Manokwari (667 cases), and Mappi 
(652 cases). However, there are also districts / 
cities that are not found clinical cases of 
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filariasis. Of the 495 districts / cities, there are 
as many as 356 (71.9%) districts / cities are 
included in filariasis endemic regions, and 139 
districts / cities are not endemic filariasis. 
(Pusat Data & Surveilans Epidemiologi, 
2010:2-3).  
  
Management of Filariasis  
  
 According to Pusat Data dan Surveilans 
Epidemiologi Kementerian Kesehatan RI 
(2010:5), there are two indicators that can be 
used to assess the effectiveness of the control 
of filariasis in Indonesia, namely the 
percentage of the district / city become 
endemic, and the percentage of clinical cases 
(lymphoedema and hydrocele) are treated per 
year> 90%. The data obtained show that the 
number of cases are treated in the year 2005 
was 1.461 people from 8423 people (17.62%), 
while in 2009, there were 4.766 people out of 
11.914 people (40%). When viewed from the 
indicator, the cases of filariasis  treated has not 
yet reach 90% so it may be said that filariasis 
control programs have not been effective.  
  One of the efforts made in the global 
filariasis elimination program is the 
administration of the mass drug for prevention 
(POMP). Mass drug prevention programs 
conducted in Indonesia in 2005-2009 was 28 
to 59.48%. While the WHO set a minimum 
target of 85% in order to break the chain of 
transmission. Although in the last 5 years there 
was an increase POMP, but the percentage of 
program being implemented is still far below 
the WHO target (Pusat Data & Surveilans 
Epidemiologi Kementerian Kesehatan RI, 
2010:5-6).  
 
Epidemiology of Filariasis  
Microfilariae level shows the 
prevalence of filariasis microfilariae in a given 
area as compared to the number of people who 
are checked. Based on data obtained from 
Subdit Filariasis Ditjen PP & PL on 2009, the 
highest microfilaria rate in Indonesia is West 
Papua (12.8%), Gorontalo (9.24%), Papua 
(6.6%), and West Sumatra (6.39%). Average 
numbers of microfilariae are determined by the 
district surveyed. In this case, not all districts 
in the provinces surveyed. While filariasis 
endemic districts in Western Indonesia  are 
61%, Midsection are 84 %, and Eastern  
Indonesia are 74%. A district is said to 
endemic if the numbers of microfilariae> 1% 
(Wahyono, 2010:10-11).  
 Filariasis cases also tend to increase from 
2005 to 2009 in the province of Indonesia, 
which has the highest number of clinical cases 
in 2009, namely: (1) Nanggroe Aceh 
Darussalam, (2) East Nusa Tenggara, (3) 
Papua, (4) Irian Jaya west, (5) Riau, and (6) 
East Kalimantan.  
 According to Wahyono (2010:12), to 
determine the endemic areas are based on 
survey results indicated by a finger prick 
endemicity of data distribution is not the same 
(unidirectional) with the distribution of the 
number of clinical cases of filariasis in each 
district / province in which district the number 
of clinical cases is not followed by many high 
microfilaria rate. There are several reasons put 
forward to explain this, among other things: 1) 
the quality of data on clinical case reports and 
surveys finger prick was poor because of 
weaknesses in the way of data collection, 2) 
different environmental conditions in each 
district, and 3) risk factors different in each 
district of the disease filariasis, and 4) host 
factors (race, ethnicity and genetic) different 
to suffer clinical filariasis.  
 Clinical cases showed indicator of disease, 
while the number of microfilaria an indicator 
of disease transmission in a region. To perform 
filariasis elimination, then the number of 
microfilaria as indicator of the success of the 
program. In contrast, chronic case 
management program must consider the 
number of clinical cases.  
 
Diagnosis of Filariasis  
    
Microfilariae into the peripheral blood 
at night, so that blood sampling is done at night 
at 20:00. Blood taken from the finger as much 
as 20-60 mL will be placed on the glass slide 
for blood preparations made thick and thin 
blood preparations, with dye staining. In 
addition to microscopic examination, 
serologic tests can also be conducted to W. 
bancrofti antigen. However, for Brugia sp 
antigen test is not yet available, but it can be 
done serologic antibody (Supali, 2010:20).  
 Elephantiasis can lead to permanent disability 
for chronic sufferers. Clinical symptoms of 
elephantiasis can be found on the feet and 
hands, as well as in the male genitalia 
(scrotum) and female (vulva and breasts). 
Type filarial worms can be distinguished 
based on clinical symptoms arise. If there is 
swelling of the entire leg or hand or genitals, 
then the cause is W. bancrofti. Whereas if 
swelling occurs only below the knee or below 
the elbow, and is not found on the genitals, 
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then the cause is Brugia sp (Supali, 2010:21).  
  
Filariasis Disease Control  
  
 Global elimination program launched by 
WHO in eliminating the causes of public 
health problems caused by filariasis in 2020. 
This program aims to reduce the prevalence of 
filariasis infection and break the chain of 
transmission. The program is implemented 
through two pillars of activity, namely: (1) 
Mass drug prevention program (POMP) to all 
residents of the district / city of endemic 
filariasis with DEC 6 mg / kg combined with 
Albendazole 400 mg once a year for 5 years, 
which aims to break the chain of transmission, 
and (2) The treatment of clinical cases of 
filariasis to prevent and reduce disability 
(Supali, 2010:22; Profil Kesehatan Indonesia, 
2010:100).  
 Since 2005, the implementation of the unit 
used in filariasis elimination program is  to 
determine the number of mass drug prevention 
administered (POMP). If a unit is found 
filariasis endemic region, the activities 
performed by the POMP target drug delivery 
for all residents of the district / city, except for 
children aged <2 years, pregnant women, 
people seriously ill, chronic filariasis patients 
who experience an acute attack, and toddlers 
with marasmus / kwashiorkor may be delayed 
treatment. Treatment aims to prevent or reduce 
disability (Profil Kesehatan Indonesia, 
2010:100).  
 
Based on the data obtained from Profil 
Kesehatan Indonesia (2010:100), filariasis 
clinical management activities in Indonesia 
tends to increase. This is indicated by an 
increase in the number of cases that have been 
handled where in 2005 there was 17.20% of 
the cases, in 2006 there were 31.10%, in 2007 
there were 29.40%, and in 2008 there was 
40.13% of cases, and decreased slightly to 
40.00% of cases in 2009 is expected in the next 
course can be increased to 90% in accordance 
with the target.  
POMP implementation filariasis 
program in Indonesia has not been efficient 
and effective because it is based on the district 
/ city, so do not reach the entire population in 
the region and there is still the risk of infection 
(reinfection). That is why this program should 
be directed to the comprehensive plan and 
covers all endemic in Indonesia (Direktorat 
P2B2 Ditjen PP & PL Kemenkes, 2010:2).  
Vector control can be done through the control 
of chemical and non-chemical control of 
vectors such as environmental management, 
biological control and genetic. Chemical 
control is done with chemicals to kill or inhibit 
the growth of vectors by spraying insecticides. 
Vector control through environmental 
management primarily devoted to agriculture, 
such as changes in swamps into agricultural 
land, thereby reducing mosquito breeding sites 
or cleaning drains. Biological vector control 
can be done by maintaining predatory fish in 
waterways (Nurjana, 2009:37-38).  
  
Socioeconomic  impact  of  filariasis 
 in Indonesia  
    
Elephantiasis (elephantiasis disease) 
is a disease that can be found in the tropics and 
subtropics. The spread of the disease in 
Indonesia covers a wide area so that if not 
taken seriously, it can lead to a decrease in 
employment productivity and huge economic 
losses. That is why, the disease is becoming 
one of the infectious diseases prioritized for 
elimination. Filariasis elimination program has 
been launched globally by the WHO since 
1999 (Direktorat P2B2 Ditjen PP & PL 
Kemenkes, 2010:1-2).  
 Elephantiasis can cause the infected people 
suffer, causing social and economic impact for 
the patients and their families. If the disease 
continues, it will affect the economy and 
become a burden in the family. In addition, 
filariasis can cause lifelong disability that 
affects the economic burden of the people, 
namely medical expenses (including 
transportation costs), and productive hours lost 
due to illness. While the social impact of social 
activity can be disrupted and discomfort.  
(Direktorat P2B2 Ditjen PP & PL Kemenkes, 
2010:33).  
According to estimates by the Ministry of 
Health of the Republic of Indonesia (2009), if 
not done filariasis control, the economic losses 
due to filariasis can reach 43 trillion dollars per 
year. To reduce this economic burden, it is 
necessary to move strategically and 
systematically in order to deal with the spread 
of filariasis in Indonesia. 
 
Filariasis Elimination Programme Action 
Plan 2010-2014  
  
  The Government of the Republic of  
Indonesia through the Ministry of Health has 
planned filariasis elimination program until  
2014 and acceleration program will continue 
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to be pursued until 2020. Filariasis elimination 
program is an accelerated program begins with 
the first 5 years starting from the year 2010 to 
the year 2014 goal of the program is to perform 
POMP filariasis to all districts / cities that are 
endemic in eastern Indonesia. POMP 
implementation considerations filariasis in 
Eastern Indonesia as a priority due to the high 
prevalence of microfilaria. As for the districts 
/ cities in Indonesia, West and Central will be 
increased to 2014 (Direktorat P2B2 Ditjen PP 
& PL Kemenkes, 2010:18).  
  There are several strategic filariasis 
elimination  programs  which  will 
 be implemented during the years 2010 - 2014, 
among other:  
1. Enhancing the role of regional heads and 
other stakeholders.   
2. Strengthening the planning and 
implementation including preparation of 
socialization in the community.   
3. Ensure  availability  of 
 drugs  and distribution, as well as 
power operations.   
4. Strengthening the implementation of 
filariasis POMP supported by the system 
of supervision and implementation of 
security co-occurring treatment and 
posttreatment. 
5. Improve monitoring and evaluation 
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